Literature DB >> 15878354

Ganoderic acid X, a lanostanoid triterpene, inhibits topoisomerases and induces apoptosis of cancer cells.

Chyi-Hann Li1, Pei-Yu Chen, Ue-Min Chang, Lou-Sing Kan, Woei-Horng Fang, Keh-Sung Tsai, Shwu-Bin Lin.   

Abstract

Lanostanoid triterpenes isolated from Ganoderma amboinense were found to inhibit the growth of numerous cancer cell lines, and some of them inhibited the activities of topoisomerases I and IIalpha in vitro. Among the bioactive isolates, one of the most potent triterpene was identified to be 3 alpha-hydroxy-15 alpha-acetoxy-lanosta-7,9(11),24-trien-26-oic acid, ganoderic acid X (GAX). Treatment of human hepatoma HuH-7 cells with GAX caused immediate inhibition of DNA synthesis as well as activation of ERK and JNK mitogen-activated protein kinases, and cell apoptosis. Molecular events of apoptosis including degradation of chromosomal DNA, decrease in the level of Bcl-xL, the disruption of mitochondrial membrane, cytosolic release of cytochrome c and activation of caspase-3 were elucidated. The ability of GAX to inhibit topoisomerases and to sensitize the cancer cells toward apoptosis fulfills the feature of a potential anticancer drug.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15878354     DOI: 10.1016/j.lfs.2004.09.045

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  21 in total

Review 1.  Ganoderic acid, lanostanoid triterpene: a key player in apoptosis.

Authors:  Balraj Singh Gill; Richa Mehra; Vicky Kumar; Sanjeev Kumar
Journal:  Invest New Drugs       Date:  2017-10-28       Impact factor: 3.850

2.  Tubulin polymerization-stimulating activity of Ganoderma triterpenoids.

Authors:  Toshitaka Kohno; Tran Hai-Bang; Qinchang Zhu; Yhiya Amen; Seiichi Sakamoto; Hiroyuki Tanaka; Satoshi Morimoto; Kuniyoshi Shimizu
Journal:  J Nat Med       Date:  2017-01-11       Impact factor: 2.343

3.  Ganoderic Acid DM: An Alternative Agent for the Treatment of Advanced Prostate Cancer.

Authors:  Benjamin M Johnson; Bently P Doonan; Faisal F Radwan; Azizul Haque
Journal:  Open Prost Cancer J       Date:  2010-01-01

4.  Validated spectrophotometric method for quantification of total triterpenes in plant matrices.

Authors:  Alessandra Moraes Pedrosa; Whocely Victor de Castro; Ana Hortência Fonseca Castro; Joaquim M Duarte-Almeida
Journal:  Daru       Date:  2020-04-13       Impact factor: 3.117

Review 5.  Historical and current perspectives on therapeutic potential of higher basidiomycetes: an overview.

Authors:  Ruby Varghese; Yogesh Bharat Dalvi; Prasad Y Lamrood; Bharat P Shinde; C K K Nair
Journal:  3 Biotech       Date:  2019-09-17       Impact factor: 2.406

Review 6.  Misconstrued versatility of Ganoderma lucidum: a key player in multi-targeted cellular signaling.

Authors:  Balraj Singh Gill; Prateek Sharma; Raj Kumar; Sanjeev Kumar
Journal:  Tumour Biol       Date:  2015-12-30

7.  Antitumor effects and mechanisms of Ganoderma extracts and spores oil.

Authors:  Chun Chen; Peng Li; Ye Li; Guan Yao; Jian-Hua Xu
Journal:  Oncol Lett       Date:  2016-08-29       Impact factor: 2.967

8.  Apoptotic and Immune Restoration Effects of Ganoderic Acids Define a New Prospective for Complementary Treatment of Cancer.

Authors:  Faisal F Y Radwan; J Manuel Perez; Azizul Haque
Journal:  J Clin Cell Immunol       Date:  2011-12-11

Review 9.  Targeting inflammatory pathways by triterpenoids for prevention and treatment of cancer.

Authors:  Vivek R Yadav; Sahdeo Prasad; Bokyung Sung; Ramaswamy Kannappan; Bharat B Aggarwal
Journal:  Toxins (Basel)       Date:  2010-10-22       Impact factor: 4.546

10.  Secondary metabolites as DNA topoisomerase inhibitors: A new era towards designing of anticancer drugs.

Authors:  Supriya Baikar; Nutan Malpathak
Journal:  Pharmacogn Rev       Date:  2010-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.